Puma Biotechnology | PBYI - EPS Earnings Per Share


Puma Biotechnology reported $0.41 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Exelixis USD 0.91 0.04 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
MacroGenics USD -0.58 0.36 Mar/2026
Moderna USD -1.97 1.43 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Takeda JPY 71.65 87.21 Jun/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026